Protokinetix, Inc. 是一家處於研發階段的生物技術公司,致力於抗衰老糖蛋白的醫學科學研究。公司總部位於俄亥俄州戴爾頓。該公司於2002年1月7日上市。公司專注於抗凍糖蛋白(AFGPs)或抗衰老糖蛋白的醫學科學研究。其抗衰老糖肽應用於眼科、皮膚科、器官移植支援和生物製造領域。AAGPs的商業應用包含多種醫療保健解決方案。該公司尚未開發出具有商業可行性的產品,也未產生任何收入。
PKTX stock price ended at $0.01 on 星期五, after rising 0.00%
On the latest trading day Feb 13, 2026, the stock price of PKTX rose by 0.00%, climbing from $0.01 to $0.01. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.01 and a high of $0.01. Notably, trading volume dropped by 476.0K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 486.0K shares were traded, equating to a market value of approximately $3.9M.